Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics

ALNY POWR Grades

• ALNY scores best on the Value dimension, with a Value rank ahead of 59.74% of US stocks.
• ALNY's strongest trending metric is Growth; it's been moving down over the last 179 days.
• ALNY ranks lowest in Momentum; there it ranks in the 12th percentile.

ALNY Stock Summary

• With a one year PEG ratio of 292.4, Alnylam Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 91.42% of US stocks.
• ALNY's price/sales ratio is 23.74; that's higher than the P/S ratio of 93.73% of US stocks.
• With a year-over-year growth in debt of 91.41%, Alnylam Pharmaceuticals Inc's debt growth rate surpasses 89.11% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Alnylam Pharmaceuticals Inc, a group of peers worth examining would be FOLD, BGNE, PXLW, CDXS, and EA.
• ALNY's SEC filings can be seen here. And to visit Alnylam Pharmaceuticals Inc's official web site, go to www.alnylam.com.

ALNY Valuation Summary

• ALNY's price/earnings ratio is -27; this is 173.97% lower than that of the median Healthcare stock.
• ALNY's EV/EBIT ratio has moved down 28.4 over the prior 210 months.
• Over the past 210 months, ALNY's price/sales ratio has gone down 400.7.

Below are key valuation metrics over time for ALNY.

ALNY Growth Metrics

Its 5 year net cashflow from operations growth rate is now at -36.34%.
• Its year over year revenue growth rate is now at 99.68%.
• Its 3 year net cashflow from operations growth rate is now at -141.56%.

Over the past 70 months, ALNY's revenue has gone up $814,382,000.

The table below shows ALNY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	844.287	-641.693	-852.824
2021-09-30	749.314	-614.696	-837.904
2021-06-30	687.534	-590.986	-886.681
2021-03-31	570.943	-604.46	-876.351
2020-12-31	492.853	-614.961	-858.281
2020-09-30	400.972	-687.797	-890.926

ALNY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ALNY has a Quality Grade of C, ranking ahead of 30.65% of graded US stocks.
• ALNY's asset turnover comes in at 0.22 -- ranking 188th of 681 Pharmaceutical Products stocks.
• QGEN, TXMD, and KMDA are the stocks whose asset turnover ratios are most correlated with ALNY.

The table below shows ALNY's key quality metrics over time.